Bicara Therapeutics prices upsized $315M offering (Pending:BCAX)09/13/2024 Clinical-stage biopharmaceutical firm Bicara Therapeutics (BCAX) priced its preliminary public offering of 17.5M shares at $18.00 per share. Bicara Therapeutics’ shares are anticipated to start buying…
